Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
7,17,28,38-tetraazatridecacyclo[24.16.2.2²,⁵.1⁸,¹².1²⁹,³³.0³,²².0⁴,¹⁹.0⁶,¹⁷.0²³,⁴³.0²⁷,³⁸.0⁴⁰,⁴⁴.0¹⁶,⁴⁶.0³⁷,⁴⁵]octatetraconta-1(42),2(48),3,5(47),6,8,10,12(46),13,15,19,21,23,25,27,29(45),30,32,34,36,40,43-docosaene-18,39-dione; 7,17,28,38-tetraazatridecacyclo[24.16.2.2²,⁵.1⁸,¹².1²⁹,³³.0³,²².0⁴,¹⁹.0⁶,¹⁷.0²³,⁴³.0²⁸,³⁹.0⁴⁰,⁴⁴.0¹⁶,⁴⁶.0³⁷,⁴⁵]octatetraconta-1(42),2(48),3,5(47),6,8,10,12(46),13,15,19,21,23,25,29,31,33,35,37(45),38,40,43-docosaene-18,27-dione
EC number: 475-310-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- JuIy 26, 2005 - Sep. 19, 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
- Reference Type:
- other: Amendment
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted April 24, 2002
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Test material form:
- solid: nanoform, no surface treatment
- Details on test material:
- - State of aggregation: solid, powder
- Particle size distribution (TEM): 29.1 nm (D50)
- Mass median aerodynamic diameter (MMAD): not specified
- Geometric standard deviation (GSD): not specified
- Shape of particles: plate
- Surface area of particles: 89 m²/g
- Crystal structure: crystalline
- Coating: no
- Surface properties: not applicable
- Density: 1566 kg/m³ at 20°C
- Moisture content: refer to IUCLID chapter 1
- Residual solvent: refer to IUCLID chapter 1
- Activation: not applicable
- Stabilisation: not applicable
Constituent 1
- Specific details on test material used for the study:
- - Physical state: Powder / black
- Storage condition of test material: Room temperature
- Analytical purity: 99.9%
- Expiration date of the lot/batch: unlimited at room temperature
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Gartenstr. 27, 33178 Borchen, Germany
- Age at study initiation: Ca. 6 - 8 weeks
- Weight at study initiation: 17.2 g - 19.1 g
- Housing: single housing
- Diet (e.g. ad libitum): Kliba-Labordiät (Maus / Ratte Haltung "GLP"), Provimi Kliba SA, Kaiseraugst, Basel, Switzerland, ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: 15 days before the first test substance application
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24°C
- Humidity (%): 30- 70%
- Air changes (per hr): fully air-conditioned rooms in which a central air-conditioning system
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: JuIy 12, 2005 (Arrival of the animals) To: Aug. 01, 2005 (Sacrifice of the animals / Determination of lymph node weight, cell count and ear weight)
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 30%
- No. of animals per dose:
- 6
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: 30% preparation in AOO 4:1 was the highest applicable concentration.
- Lymph node proliferation response: The results did not show increased lymph node parameters and ear weights after application of a 30% preparation in AOO 4:1.Therefore this dose level was selected for the main study.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response:
The parameters used to characterize the response are lymph node cell count and to a certain extent weight. Because not only sensitization induction but also irritation of the ear skin by the test substance may induce Iymph node responses, the weight of ear punches taken from the area of test substance application is determined as a parameter for inflammatory ear swelling serving as an indicator for the irritant action of the test substance.
If a test substance does not show a statistically significant and/or biologically relevant increase in cell count and/or Iymph node weight as compared to the vehicle control in the presence of statistically significantly and/or biologically relevant increased ear weights as indication of skin irritation, it is considered not to be a sensitizer.
If at least one concentration tested causes a concentration dependent statistically significant and/or biologically relevant increase in cell count and/or lymph node weight without being accompanied by a statistically significant and/or biologically relevant increase in ear weight, the test substance is considered to be a sensitizer (this was not the case for the test substance).
If statistically significant and/or biologically relevant increases in ear weights are running in parallel to the increase in cell count and/or lymph node weight, it cannot be ruled out, that the lymph node response was caused by irritation and not by skin sensitization. Then, for identification of the relevance of the statistical evaluation, a comparison of the results of the present test to appropriate historical control values may be performed. If one or a combination of the measured parameters change statistical significance, evaluation on basis of the criteria described above may be possible. If the
statistical comparison with the historical control does not yield results useful for evaluation, further investigations may be necessary to differentiate between irritation and sensitization response (comparison with historical controls were not necessary in this study).
If a test substance does not elicit a statistical significant increase in lymph node weight and/or cell count but shows a clear concentration related increase in response, further investigating of the sensitization potential at higher concentrations should be considered (this was not the case for the test substance).
TREATMENT PREPARATION AND ADMINISTRATION:
The test substance preparation was produced on a weight by weight (w/w) basis shortly before the application by stirring with a high speed homogenizer (Ultra-Turrax) and a magnetic stirrer. The test substance was applied as a suspension for all applications.
Epicutaneous application is simulating dermal contact with the compound which is possible to occur under practical use conditions.
Application volume: 25 µL per ear
Site of application: Dorsal part of both ears
Frequency of application: 3 consecutive applications (day 0 - day 2) to the same application site
The animals were treated with vehicle or test substance preparation and were sacrificed on study day 5 by cervical dislocation.
Immediately after the death of each animal a circular piece of tissue (diameter 0.8 cm) was punched out of the apical part of each ear. The weight of the pooled punches was determined for each animal.
Immediately after removal of the ear punches the left and right auricular lymph nodes were dissected. The weight of the pooled lymph nodes from both sides was determined for each animal.
After weight determination, the pooled lymph nodes of each animal were stored in phosphate buffered saline in an ice-water bath until further preparation. A single cell suspension was prepared as soon as possible after dissection by carefully passing the lymph nodes through an iron mesh (mesh size 200 µm) into 6 mL of phosphate-buffered physiological saline. For determination of cell count the standard suspension was further diluted with Casy®ton in a ratio 1:500. The cell count was determined using a Casy®-Counter. Each suspension was measured in triplicate (3 dilutions of the standard suspension). The mean of the triplicate measurements was used for further evaluation. - Positive control substance(s):
- other: A concurrent positive control (reliability check) with a known sensitizer was not included into this study (for details see: Any other informations on materials and methods).
- Statistics:
- Mean values and standard deviations of the measured parameters were calculated for the test and control groups from the individual values. The indices of lymph node weight, ceII count and ear weight were calculated as the ratio of the test group mean values for these parameters divided by those of the vehicle control group.
Lymph node weight, celI count and ear weight: WILCOXON - Test
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- other: Lymph node weight index
- Value:
- 0.86
- Variability:
- 1.00 (control)
- Test group / Remarks:
- 30% in AOO 4:1
- Parameter:
- other: Cell count index
- Value:
- 0.81
- Variability:
- 1.00 (control)
- Test group / Remarks:
- 30% in AOO 4:1
- Parameter:
- other: Ear weight index
- Value:
- 1.04
- Variability:
- 1.00 (control)
- Test group / Remarks:
- 30% in AOO 4:1
- Cellular proliferation data / Observations:
- Treatment of the mice with a 30% test substance preparation induced no statistically significant increase in lymph node cell counts or lymph node weights when compared to the vehicle control group. On the 2nd and 3rd day of application and on the day of lymph node removal slight black discolored ears were noticed in all animals of the test group. Treatment of mice induced a statistically significant increase in ear weight as compared to vehicle control group which indicates some irritation of the ear at this concentration. The expected body weight gain was generally observed in the course of the study. No abnormalities were observed during general observation. Lymph node weight and cell count: Test group mean values / standard deviations / indices Lymph Node Weight [mg] 1.) vehicIe AOO 4:1: 6.0 / 1.0 / 1.0 2.) 30% in AOO 4:1: 5.2 / 0.6 / 0.86 Cell Counts [Counts/Lymph Node Pair] 1.) vehicIe AOO 4:1: 12.859.667 / 2.888.022 / 1.0 2.) 30% in AOO 4:1: 10.449.333 / 1.761.782 / 0.81 Ear weight [mg]: Test group mean values / standard deviations / indices 1.) vehicIe AOO 4:1: 28.9 / 1.0 / 1.0 2.) 30% in AOO 4:1: 30.1 / 1.0 / 1.04 # SD standard deviation # statistically significant for the value p = 0.05 index: test group x / test group 1 (vehicle control)
Any other information on results incl. tables
No signs of systemic toxicity were noticed. On the 2nd and 3rd day of application and on the day of lymph node removal slight black discoloration of the ears were noticed in all animals of the test group.
The test substance did not induce a statistically significant or biologically relevant response of the auricular lymph nodes when applied as a 30% preparation in AOO 4:1.
The limited, but statistically significant increase in ear weight indicates some irritation of the ear at this concentration. The test article does not have a skin sensitising effect in the Murine Local Lymph Node Assay under the test conditions chosen.
t
Mean indices (= fold of change as compared to the vehicle control):
===========================================================
* Indices * Lymph node * cell * ear *
* * weight * count * weight *
===========================================================
* vehicle AOO 4:1 * 1.00 * 1.00 * 1.00 *
* 30% in AOO 4:1 * 0.86 * 0.81 * 1.04 *
===========================================================
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- From the results of the study it is concluded, that the test article does not have a skin sensitizing effect in the Murine Local Lymph Node Assay under the test conditions chosen.
- Executive summary:
The skin sensitizing potential of the test substance was assessed using the non-radioactive variant of the Murine Local Lymph Node Assay based on the OECD guideline 429 and in accordance with GLP. The assay simulates the induction phase for skin sensitization in mice. It determines the response of the auricular Iymph nodes on repeated application of the test substance to the dorsal skin of the ears.
Groups of 6 female CBA/Ca mice each were treated with a 30% w/w preparation of the test substance (highest applicable concentration) in AOO 4:1 (mixture of acetone:olive oil Ph.Eur./DAB in a ratio 4:1 parts by volume) or with the vehicle alone. The study used 1 test group and 1 control group. Each test animal was applied with 25 µL per ear of the respective test substance preparation to the dorsum of both ears for three consecutive days. The control group was treated with 25 µL per ear of the vehicle alone. Three days after the last application the mice were sacrificed and the auricular lymph nodes were removed. Lymph node response was evaluated by measuring the cellular content (indicator of cell proliferation) and weight of each animal's pooled lymph nodes. Moreover, a defined area with a diameter of 0.8 cm was punched out of the apical part of each ear and for each animal the weight of the pooled punches was determined in order to obtain an indication of possible skin irritation.
No signs of systemic toxicity were noticed. On the 2nd and 3rd day of application and on the day of lymph node removal slight black discoloration of the ears were noticed in all animals of the test group. The test substance did not induce a statistically significant or biologically relevant response of the auricular lymph nodes when applied as a 30% preparation in AOO 4:1. The limited, but statistically significant increase in ear weight indicates some irritation of the ear at this concentration. In conclusion, the test article does not have a skin sensitizing potential in the Murine Local Lymph Node Assay under the test conditions chosen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Embora a ECHA disponibilize muito material em linha na sua língua, uma parte desta página está disponível apenas em inglês. Mais informações sobreas práticas de multilinguismo da ECHA.
Bem-vindo ao sítio Web da ECHA O navegador Internet Explorer 7 (e versões anteriores) não é totalmente suportado por este sítio Web. Por favor atualize o seu Internet Explorer para uma versão mais recente.
Este sítio Web utiliza cookies a fim de garantir a melhor experiência possível nos nossos sítios Web.
Saiba mais sobre como utilizar cookies.